Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 0

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 0
---
Item
1. Financial Statements

CERO
THERAPEUTICS HOLDINGS, INC.

CONDENSED
CONSOLIDATED BALANCE SHEETS

    June 30,  
    December 31, 

    2025  
    2024 

    (Unaudited)  

    ASSETS 

    Current assets: 

    Cash, restricted cash, and cash equivalents 
    $3,302,674  
    $3,327,060 
  
    Prepaid expenses and other current assets 
     443,892  
     274,749 
  
    Investment in equity securities, at cost 
     500,000  
     - 
  
    Deferred offering costs 
     -  
     112,232 
  
    Total current assets 
     4,246,566  
     3,714,041 

    Deferred offering costs, net of current portion 
     500,000  
     500,000 
  
    Operating lease right-of-use assets 
     1,072,950  
     1,464,367 
  
    Property and equipment, net 
     382,806  
     528,521 
  
    Total assets 
    $6,202,322  
    $6,206,929 

    LIABILITIES AND STOCKHOLDERS’ DEFICIT 

    Current liabilities: 

    Accounts payable 
    $6,213,045  
    $4,507,318 
  
    Accrued liabilities 
     365,060  
     1,913,175 
  
    Operating lease liability 
     934,310  
     876,392 
  
    Earnout liability 
     20,000  
     20,000 
  
    Deemed dividend – common stock liability, 692 shares 
     85,500  
     85,500 
  
    Total current liabilities 
     7,617,915  
     7,402,385 

    Operating lease liability, net of current portion 
     218,308  
     699,107 
  
    Total liabilities 
     7,836,223  
     8,101,492 

    Commitments and contingencies 

    Stockholders’ deficit: 

    Series C convertible preferred stock, $0.0001 par value